Page last updated: 2024-09-05

cilengitide and Lymphoma, T-Cell

cilengitide has been researched along with Lymphoma, T-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, H; Amorós, M; Bolontrade, M; Cayrol, F; Cerchietti, L; Cremaschi, GA; Díaz Flaqué, MC; Farías, RN; Fernando, T; Inghirami, G; Isse, B; Singh, A; Sterle, HA; Tabbò, F; Tian, YF; Yang, SN1

Other Studies

1 other study(ies) available for cilengitide and Lymphoma, T-Cell

ArticleYear
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells.
    Blood, 2015, Jan-29, Volume: 125, Issue:5

    Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Integrin alphaVbeta3; Jurkat Cells; Lymphoma, T-Cell; Male; Mice; Mice, SCID; Neoplasm Transplantation; Neovascularization, Pathologic; RNA, Small Interfering; Signal Transduction; Snake Venoms; T-Lymphocytes; Thyroid Hormones; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2015